Wei Yu
- Molecular Biology top 2%
- Congenital heart defects research 25
- CRISPR and Genetic Engineering 16
- Microbial Metabolic Engineering and Bioproduction 13
- Epigenetics and DNA Methylation 9
- Ubiquitin and proteasome pathways 8
- Fungal and yeast genetics research 8
- RNA modifications and cancer 7
- Aging top 5%
- Cell Biology top 5%
- Genetics top 2%
-
- Biofuel production and bioconversion 9
Wei Yu
96 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 3.2k
- Business and International Management 74
- Aging 51
- Cell Biology 440
- Genetics 713
Countries citing papers authored by Wei Yu
This map shows the geographic impact of Wei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yu more than expected).
Fields of papers citing papers by Wei Yu
This network shows the impact of papers produced by Wei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yu. The network helps show where Wei Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 103 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 30 | |
| 7 | 2020 | 53 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 30 | |
| 10 | 2019 | 45 | |
| 11 | 2018 | 7 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 139 | |
| 14 | 2016 | 63 | |
| 15 | 2015 | 29 | |
| 16 | 2015 | 7 | |
| 17 | 2014 | 147 | |
| 18 | 2013 | 28 | |
| 19 | 2011 | 22 | |
| 20 | 2005 | 185 |
About Wei Yu
Wei Yu is a scholar working on Molecular Medicine, Molecular Biology and Aging, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Congenital heart defects research (25 papers), CRISPR and Genetic Engineering (16 papers), Microbial Metabolic Engineering and Bioproduction (13 papers), Epigenetics and DNA Methylation (9 papers), Biofuel production and bioconversion (9 papers), Ubiquitin and proteasome pathways (8 papers), Fungal and yeast genetics research (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Molecular Biology (3.2k citations), Business and International Management (74 citations) and Aging (51 citations). Wei Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yongjin J. Zhou, Robert J. Schwartz, Jiaoqi Gao, Bin Zhou, Lingjuan He, Xueliang Zhu, Xiaoxin Zhai, Hui Yang, Yan Li and Yidi Sun. Their work appears in journals such as Journal of Biological Chemistry, Development, Synthetic and Systems Biotechnology, Microbiology Spectrum and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.